TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Kangji Medical Holdings Limited ( (HK:9997) ) has shared an announcement.
Kangji Medical Holdings Limited has announced a proposal for its privatization through a scheme of arrangement, which has been approved by the Scheme Shareholders and Independent Shareholders at the Court Meeting and EGM held on November 10, 2025. The approval includes the cancellation of Scheme Shares and issuance of new shares to the Offeror, Knight Bidco Limited, with the expected withdrawal of Kangji Medical’s shares from the Stock Exchange set for December 9, 2025. This move signifies a strategic shift in the company’s operational structure, potentially impacting its market positioning and shareholder dynamics.
The most recent analyst rating on (HK:9997) stock is a Buy with a HK$10.00 price target. To see the full list of analyst forecasts on Kangji Medical Holdings Limited stock, see the HK:9997 Stock Forecast page.
More about Kangji Medical Holdings Limited
Kangji Medical Holdings Limited is a company incorporated in the Cayman Islands, operating within the medical industry. The company is primarily focused on providing medical devices and solutions, with a market focus likely on healthcare and medical sectors.
YTD Price Performance: 49.36%
Average Trading Volume: 4,602,932
Technical Sentiment Signal: Buy
Current Market Cap: HK$10.69B
Find detailed analytics on 9997 stock on TipRanks’ Stock Analysis page.